Literature DB >> 27770187

[Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].

S F Lax1, L-C Horn2, T Löning3.   

Abstract

In the 2014 WHO classification, squamous cell precursor lesions are classified as low-grade and high-grade intraepithelial lesions. LSIL corresponds to CIN1, HSIL includes CIN2 and CIN3. Only adenocarcinoma in situ (AIS) is accepted as precursor of adenocarcinoma and includes the stratified mucin-producing intraepithelial lesion (SMILE). Although relatively rare, adenocarcinoma and squamous cell carcinoma can be mixed with a poorly differentiated neuroendocrine carcinoma. Most cervical adenocarcinomas are low grade and of endocervical type. Mucinous carcinomas show marked intra- and extracellular mucin production. Almost all squamous cell carcinomas, the vast majority of adenocarcinomas, and many rare carcinoma types are HPV related. For low grade endocervical adenocarcinomas, the pattern-based classification according to Silva should be reported. Neuroendocrine tumors are rare and are classified into low-grade and high-grade, whereby the term carcinoid is still used.

Entities:  

Keywords:  Adenocarcinoma; Carcinoma in situ; Human papilloma virus; Immunohistochemistry; Squamous intraepithelial lesions of the cervix

Mesh:

Year:  2016        PMID: 27770187     DOI: 10.1007/s00292-016-0247-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  21 in total

1.  Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?

Authors:  J J Park; D Sun; B J Quade; C Flynn; E E Sheets; A Yang; F McKeon; C P Crum
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.

Authors:  Mark H Stoler; Michelle D Vichnin; Alex Ferenczy; Daron G Ferris; Gonzalo Perez; Jorma Paavonen; Elmar A Joura; Henning Djursing; Kristján Sigurdsson; Lucy Jefferson; Frances Alvarez; Heather L Sings; Shuang Lu; Margaret K James; Alfred Saah; Richard M Haupt
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

3.  Allelic deletion mapping on chromosome 6q and X chromosome inactivation clonality patterns in cervical intraepithelial neoplasia and invasive carcinoma.

Authors:  R Chuaqui; M Silva; M Emmert-Buck
Journal:  Gynecol Oncol       Date:  2001-03       Impact factor: 5.482

4.  Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.

Authors:  Andrea Diaz De Vivar; Andres A Roma; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Brent Arville; Norihiro Teramoto; Rouba Ali-Fehmi; Joanne K L Rutgers; Farah Tabassum; Denise Barbuto; Irene Aguilera-Barrantes; Alexandra Shaye-Brown; Dean Daya; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2013-11       Impact factor: 2.762

Review 5.  Endocervical glandular lesions: controversial aspects and ancillary techniques.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

6.  Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.

Authors:  Nicolas Wentzensen; Lauren Schwartz; Rosemary E Zuna; Katie Smith; Cara Mathews; Michael A Gold; R Andy Allen; Roy Zhang; S Terence Dunn; Joan L Walker; Mark Schiffman
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

Review 7.  [Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Authors:  S F Lax; K F Tamussino; P F Lang
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

8.  Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix.

Authors:  Chie Kuragaki; Takayuki Enomoto; Yuko Ueno; Hongbo Sun; Masami Fujita; Ryuichi Nakashima; Yutaka Ueda; Hiroko Wada; Yuji Murata; Toshihiko Toki; Ikuo Konishi; Shingo Fujii
Journal:  Lab Invest       Date:  2003-01       Impact factor: 5.662

Review 9.  New developments in endocervical glandular lesions.

Authors:  W Glenn McCluggage
Journal:  Histopathology       Date:  2012-11-08       Impact factor: 5.087

Review 10.  The biology and life-cycle of human papillomaviruses.

Authors:  John Doorbar; Wim Quint; Lawrence Banks; Ignacio G Bravo; Mark Stoler; Tom R Broker; Margaret A Stanley
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

View more
  5 in total

1.  Association of low expression of E-cadherin and β-catenin with the progression of early stage human squamous cervical cancer.

Authors:  Jing Jiang; Xinling Li; Xiangmei Yin; Jieying Zhang; Bin Shi
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

2.  Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.

Authors:  Saliha Sağnıç; Özer Birge; Mehmet Sait Bakır; Ceyda Karadag; Tayup Şimşek
Journal:  Int J Surg Oncol       Date:  2021-09-16

3.  Neuroendocrine carcinoma of the cervix: a systematic review of the literature.

Authors:  Clemens B Tempfer; Iris Tischoff; Askin Dogan; Ziad Hilal; Beate Schultheis; Peter Kern; Günther A Rezniczek
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

Review 4.  Synchronous Cervical Adenocarcinoma and Ovarian Serous Adenocarcinoma-A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Irina Cecilia Balescu; Camelia Diaconu; Simona Dima; Laura Iliescu; Mihaela Vilcu; Alexandru Filipescu; Ioana Halmaciu; Dragos Cretoiu; Iulian Brezean
Journal:  Medicina (Kaunas)       Date:  2020-03-29       Impact factor: 2.430

5.  Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study.

Authors:  Xin Hu; Mingxia Jing; Mei Zhang; Ping Yang; Xiaolong Yan
Journal:  Health Qual Life Outcomes       Date:  2020-10-02       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.